Trial Profile
An Open Label Non- Randomized Multicentric Phase II Study of Sunitinib Before and During Radiotherapy in Newly Diagnosed Biopsy-only Glioblastoma Patients.
Status:
Completed
Phase of Trial:
Phase II
Latest Information Update: 28 Apr 2017
Price :
$35
*
At a glance
- Drugs Sunitinib (Primary)
- Indications Glioblastoma
- Focus Therapeutic Use
- 19 Jan 2012 Actual end date (Jan 2012) added as reported by ClinicalTrials.gov.
- 19 Jan 2012 Actual patient number (12) added as reported by ClinicalTrials.gov.
- 19 Jan 2012 Status changed from recruiting to completed as reported by ClinicalTrials.gov.